Montenegro quer que 50 anos do 25 de Abril marquem "ponto de viragem" na retenção de talento dos jovens

[rg7803]

re-encontrei esta acção. No finviz tem um forte breakout!
rg7803, tens opiniao?
LW

olá boa tarde

está no bom caminho, ascendente e com bom nível actividade
penso que o break já terá acontecido uns dias atrás
se entrares não compres tudo duma vez
boa sorte!

[LoneWolf]

re-encontrei esta acção. No finviz tem um forte breakout!
rg7803, tens opiniao?
LW

[pcm1979]

Muito interessante. Só falta conhecer a realidade da empresa.

[zeef]

Será o target price de algum analista ?

http://finviz.com/quote.ashx?t=CLVS&ty=c&ta=1&p=d

Luka porque não coloca as tuas ideias num tópico : Trading Ideas hehe

zeef,

[rg7803]

Gostei do gráfico!
Só não entendi esse target dos 48$. Porquê Luka?

[Luka!]

FUNDAMENTALS

Clovis Oncology Inc (CLVS) Surges After Hayman Capital’s Report
Clovis Oncology stock boosted after Hayman Capital reported that the company was punished a bit too much for its cancer drug failure
Nov 25, 2015 at 1:23 pm Est

By Hannah Ishmael on Nov 25, 2015 at 1:23 pm Est

Clovis Oncology Inc. (NASDAQ:CLVS) stock surged more than 3.50% in midday trading today, after Hayman Capital posted a presentation on Hightail, a sharing site. Through this newly-published report, the firm stated that Clovis was exaggeratedly punished for merely disappointing news on Rociletinib, its cancer drug.

On November 16, Clovis announced that the Food and Drug Administration (FDA) required more in-depth and clear results for Rociletinib. However, the company failed to provide clear results, with a reduced success ratio in the trials.

Furthermore, Hayman Capital stated that Clovis’ fundamentals are likely to favor the $45 target price for 2016, and a bullish case of $90. It also explained that the recent stock pullback is an excellent buying opportunity.

TECHNICAL ANALYSIS
the chart is self-explanatory
Deeply Oversold / rsi=19
entering lower Bollinger Band

TRADING PLAN
Buy zone 30-33$
Terget 48$